Track Amrutanjan Health Care Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 0.53 %
Low
493.0
High
516.0
1 Month returns: -4.21 %
Low
482.6
High
550.5
1 Year returns: -34.43 %
Low
482.6
High
784.8
3 Year CAGR: -8.09 %
Low
482.6
High
862.6
5 Year CAGR: -6.98 %
Low
482.6
High
1,024.6
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Amrutanjan Health Care Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Amrutanjan Health Care Ltd. Shareholding Pattern
Quarterly breakdown of Amrutanjan Health Care Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Amrutanjan Health Care Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Amrutanjan Health Care Ltd.?
The current share price of Amrutanjan Health Care Ltd. is ₹ 501.00 as of 8 Sep 2026.
What is the market capitalisation of Amrutanjan Health Care Ltd.?
The market capitalisation of Amrutanjan Health Care Ltd. stands at ₹ 1,447.79 Cr.
What is the PE ratio of Amrutanjan Health Care Ltd.?
The Price-to-Earnings (PE) ratio of Amrutanjan Health Care Ltd. is 26.82 as of the latest trailing twelve months data.
What is the ROE and ROCE of Amrutanjan Health Care Ltd.?
Amrutanjan Health Care Ltd. has a Return on Equity (ROE) of 16.62% and a Return on Capital Employed (ROCE) of 19.80% as per the latest financial reports.
What is the 52-week high and low of Amrutanjan Health Care Ltd.?
The 52-week high of Amrutanjan Health Care Ltd. is - and the 52-week low is -.
What is the dividend yield of Amrutanjan Health Care Ltd.?
The dividend yield of Amrutanjan Health Care Ltd. is 0.98% based on the current market price.
What is the FII and DII holding in Amrutanjan Health Care Ltd.?
Foreign Institutional Investors (FII) hold 2.44%, Domestic Institutional Investors (DII) hold 5.91% and retail/public investors hold 37.16% of Amrutanjan Health Care Ltd. shares.
What sector does Amrutanjan Health Care Ltd. belong to?
Amrutanjan Health Care Ltd. operates in the Healthcare sector.
What is the beta of Amrutanjan Health Care Ltd.?
The beta of Amrutanjan Health Care Ltd. is 0.46, indicating its price volatility relative to the broader market. Over the past 1 year, Amrutanjan Health Care Ltd. has delivered an absolute return of -31.34%.
What is the RSI of Amrutanjan Health Care Ltd.?
The 14-day Relative Strength Index (RSI) of Amrutanjan Health Care Ltd. is 44.01, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Company Profile
Overview of Amrutanjan Health Care Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene and services in pain management. Its segments include OTC Products, Women Hygiene, Beverages and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Women Hygiene includes Comfy Snug Fit, Comfy Snug Fit Extra Long, and Comfy Snug Fit Ultra XL. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint.
Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene and services in pain management. Its segments include OTC Products, Women Hygiene, Beverages a...
Key personnel
Mr. N. Swaminathan
Chief Financial Officer
Mr. Mani Bhagavatheeswaran
Chief Marketing Officer
Mr. Gagan Preet Singh
General Manager - Legal, Company Secretary & Compliance Officer
Mr. S. Jeyakanth
Chief Operating Officer - Supply Chain and Product Delivery
Mr. Soumomoy Pal
Associate Vice President - Information Technology
Dr. J. Ravichandran
Associate Vice President - QC/ QA/ R&D
Mr. Sambhu Prasad SivalenkaD
Executive Chairman of the Board, Managing Director
103, (Old No. 42-45),, Luz Church Road. Mylapore,, CHENNAI, 600004, India
Stock Analysis
Fundamental analysis overview of Amrutanjan Health Care Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
High and stable ROE
The company reported strong ROE of 16.62% for 12-month ended 30 Jun 2026 and ROE improved marginally by 9 bps from 1 year ago
What is ROE (FY)?
Moderate operating margin but improving trend
The company reported moderate operating margin of 13.8% for 12-month ended 30 Jun 2026 but operating margin improved by 154 bps from 1 year ago
What is Operating profit margin?
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.0 as on 30 Jun 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 10 financial years
What is Dividend streak?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Weak price momentum
Price Momentum score of 17.8 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term
What is Price Momentum score?
17.8 / 100
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -1.03% for 12-month ended 30 Jun 2026 and the growth was 8.23 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Low dividend yield
The company has a low dividend yield of 0.98%
What is Dividend yield?
Neutral
Stock appears expensive but is at a discount to industry median P/E
PE TTM of 26.82 indicates that the stock is expensive on a standalone basis but discount to industry median P/E is decent at -15.61%
What is P/E Ratio?
Median: 31.78
Value 26.82
-0.96721.13
Moderate revenue growth and in line with median growth of industry
The company delivered moderate revenue growth of 10.68% for 12-month ended 30 Jun 2026 and the growth was 0.09 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 10.59
Value 10.68
-99.6111701.8
Company's earnings are of moderate quality
Earnings quality score of 51.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
51.0 / 100
No red flags found!
No significant red flags found in the stock.
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Index Presence
Amrutanjan Health Care Ltd. is not part of any tracked index.